Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fed-condition bioequivalence study of celecoxib 400 mg in healthy Thai volunteers
TCTR20170807001Not yet recruiting
- Sponsor
- All Research
- Start
- Oct 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of celecoxib (2 arms), sponsored by All Research. Primary endpoints: Cmax, AUC0-t and 2 more. Planned start Oct 2017; status: not yet recruiting.
02
Drugs
celecoxib
Beyond the preview
Go deeper on TCTR20170807001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170807001.